Navigation Links
Lexicon Pharmaceuticals to Present at the Wedbush 2011 Life Sciences Management Access Conference
Date:8/11/2011

THE WOODLANDS, Texas, Aug. 11, 2011 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on discovering breakthrough treatments for human disease, announced today that Arthur T. Sands, M.D., Ph.D., Lexicon's president and chief executive officer, will present at the Wedbush 2011 Life Sciences Management Access Conference on Tuesday, August 16, 2011 at 1:15 p.m. Eastern Time in New York City.  Dr. Sands will provide an overview on Lexicon's clinical development programs and milestones.

A live webcast of the event may be accessed on Lexicon's corporate website at www.lexpharma.com.  An archived version of the webcast will be available for 30 days after the event on the company's website.

About Lexicon

Lexicon is a biopharmaceutical company focused on discovering breakthrough treatments for human disease.  Lexicon currently has four drug programs in mid-stage development for diabetes, irritable bowel syndrome, carcinoid syndrome and rheumatoid arthritis, all of which were discovered by Lexicon's research team.  Lexicon has used its proprietary gene knockout technology to identify more than 100 promising drug targets.  Lexicon has focused drug discovery efforts on these biologically-validated targets to create its extensive pipeline of clinical and preclinical programs.  For additional information about Lexicon and its programs, please visit www.lexpharma.com.

Safe Harbor Statement

This press release contains "forward-looking" statements, including statements relating to Lexicon's growth and future operating results, discovery and development of products, strategic alliances and intell
'/>"/>

SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Lexicon Announces Publication of Results From the Phase 2 Trial of LX1031 in Patients With Irritable Bowel Syndrome in Journal of Gastroenterology
2. Phase 2 Trial of Lexicons LX1032, Telotristat Etiprate, Shows Positive Results in Carcinoid Syndrome
3. Lexicon Pharmaceuticals Reports on Clinical Program Status and 2011 Second Quarter Results
4. Lexicons IBS Drug Candidate, LX1033, Successfully Completes Phase 1 Clinical Trial
5. Lexicon Presents LX4211 Mechanism of Action Data at American Diabetes Association Meeting and Announces Commencement of Phase 2b Clinical Trial in Type 2 Diabetes
6. Lexicon Pharmaceuticals Announces Webcast of 2011 Annual R&D Day
7. Lexicon Pharmaceuticals Reports on Clinical Program Status and 2011 First Quarter Results
8. Lexicon to Provide First Quarter 2011 Financial Results
9. Lexicon Pharmaceuticals Appoints Dr. Pablo Lapuerta Chief Medical Officer
10. Lexicon Pharmaceuticals to Present at the Cowen and Company 31st Annual Health Care Conference
11. Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2010 Fourth Quarter and Full Year Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... March 27, 2015  Victoria Vein & Surgery Clinic is ... Astanza Duality laser in Victoria, Texas . ... well as advanced laser treatments for a variety of medical ... industry to provide more services for their patients. Since adding ... Victoria residents get rid of their ...
(Date:3/27/2015)... VEGAS , March 27, 2015 Zimmer Holdings, ... efficient external fixation system for trauma patients. ... XtraFix ® External Fixation System from Zimmer ... technology and materials.   The XtraFix System ... clamps from the external fixation process, resulting in saved time, ...
(Date:3/27/2015)... -- According to a new market research ... Ultrasound), Ablation Catheter (Cryoablation, RF, Microwave), Lab Devices (Mapping, ... - Global Forecasts to 2019 ", published by MarketsandMarkets, the ... Billion by 2019 with a CAGR of around 10.3% ... Browse   90   ma rket data ...
Breaking Medicine Technology:Victoria Vein And Surgery Clinic Uses Advanced Astanza Duality Tattoo Removal Technology 2Zimmer Debuts New Modular External Fixation System 2Zimmer Debuts New Modular External Fixation System 3Electrophysiology (EP) Market Worth $4.73 Billion by 2019 2Electrophysiology (EP) Market Worth $4.73 Billion by 2019 3Electrophysiology (EP) Market Worth $4.73 Billion by 2019 4
... LOS ANGELES, June 21, 2011 Within the last two ... safest, most convenient weight loss procedure for obese individuals. As ... procedure has exponentially increased as well, with the caliber of ... Based in Los Angeles, a bariatric surgeon named Dr. Michael ...
... Inc. (NASDAQ: ESRX ) said today it ... prescription drugs affordable and accessible for American families.   ... these challenging economic times, it is critical that we ... said Express Scripts, chairman and CEO George Paz.  "It ...
Cached Medicine Technology:VIP Care for Lap Band Patients Leads to Life Changing Results 2Express Scripts Strives to Make Prescription Drugs Affordable and Accessible to American Families 2Express Scripts Strives to Make Prescription Drugs Affordable and Accessible to American Families 3Express Scripts Strives to Make Prescription Drugs Affordable and Accessible to American Families 4
(Date:3/28/2015)... Coffee could not only perk you up in the ... researchers have found. , They found that those who drank ... Antioxidants fight gum disease. Does coffee, then, help fight gum ... M. Goldman School of Dental Medicine explored in a ... Journal of Periodontology. , “This is the first long-term study ...
(Date:3/28/2015)... March 28, 2015 Take a bite ... kicks into action. Acids tumble into the stomach, ready ... faulty valve-like structure lets these acids run amok, triggering ... extremely common symptom. More than 60 million Americans have ... examine where heartburn starts, and how it can be ...
(Date:3/28/2015)... The California-based leading wig brand UniWigs ... shopping on UniWigs during the Easter Holidays from today ... promotion on April Fools’ Day. , As the winter ... the corner. Easter Festival, with religious origins to countries ... holiday after Christmas. The best wig provider, UniWigs, would ...
(Date:3/28/2015)... An article in Fortune on Monday, ... critical to organizations that deal with PCI (Payment Card ... data security, is worsening . Using numbers from ... major category out of the twelve measured improved, barring ... the craziness that has gone on in the retail ...
(Date:3/28/2015)... 2015 One in three young athletes ... presented today at the American Orthopaedic Society for Sports ... the long term success of surgery for patients aged ... data from 242 patients who underwent ACL reconstruction between ... MBBS, FRACS, from North Sydney Orthopaedic and Sports Medicine ...
Breaking Medicine News(10 mins):Health News:New Research Impliments Coffee May Help Fight Gum Disease and Increasing Benefits With Tylers Coffee 2Health News:Bypass Your Heartburn Worries This Easter With Tylers Coffee 2Health News:UniWigs Is Sending Out Mysterious Gifts During the Easter Holidays 2Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 2Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 3Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 4Health News:Young Athletes at Greater Risk for Re-Injury after ACL Surgery 2
... interference (RNAi) represents an innovative new strategy for using ... disease processes, and a series of review articles describing ... microRNAs will begin with two review papers in the ... Gene Therapy, a peer-reviewed journal published by Mary Ann ...
... today at 10:00 a.m. EST by calling, ... the Web at: http://www.airproducts.com/Invest/financialnews/EarningsReleases.htm ... Products,(NYSE: APD ) today reported net income of ... for its fiscal first quarter ended December 31,2007. Net ...
... Indoor and Outdoor Allergies, KENILWORTH, N.J., ... today announced that the U.S. Food and ... (loratadine), which clearly,tells consumers that the non-drowsy ... indoor (also called perennial or,year-round) and outdoor ...
... with the hospital laundry, FORT WORTH, Texas, Jan. 22 ... Memorial Medical Center after,the hospital staff sent their newborn son,s ... 8, 2007, Kourtney McGee gave birth to her son, Jacob ... taken to the,hospital morgue., As Ms. McGee and Milburn ...
... elements of new data, WASHINGTON, Jan. 22 ... of existing data on the efficacy,of oral over-the-counter ... review includes a limited number of OTC medicines ... statistically significant,improvement in adult populations., The Consumer ...
... Iowa An Iowa State University researcher who spent ... findings published in the journal Nature this week. , ... and is the most-cited weekly science journal in the ... evolution and organismal biology department, has been working with ...
Cached Medicine News:Health News:The RNA drug revolution -- a new approach to gene therapy 2Health News:Air Products Reports Q1 EPS Up 16% on Volume Growth and Improved Margins; Raises 2008 Full Year EPS Guidance 2Health News:Air Products Reports Q1 EPS Up 16% on Volume Growth and Improved Margins; Raises 2008 Full Year EPS Guidance 3Health News:Air Products Reports Q1 EPS Up 16% on Volume Growth and Improved Margins; Raises 2008 Full Year EPS Guidance 4Health News:Air Products Reports Q1 EPS Up 16% on Volume Growth and Improved Margins; Raises 2008 Full Year EPS Guidance 5Health News:Air Products Reports Q1 EPS Up 16% on Volume Growth and Improved Margins; Raises 2008 Full Year EPS Guidance 6Health News:Air Products Reports Q1 EPS Up 16% on Volume Growth and Improved Margins; Raises 2008 Full Year EPS Guidance 7Health News:Air Products Reports Q1 EPS Up 16% on Volume Growth and Improved Margins; Raises 2008 Full Year EPS Guidance 8Health News:Air Products Reports Q1 EPS Up 16% on Volume Growth and Improved Margins; Raises 2008 Full Year EPS Guidance 9Health News:Air Products Reports Q1 EPS Up 16% on Volume Growth and Improved Margins; Raises 2008 Full Year EPS Guidance 10Health News:Air Products Reports Q1 EPS Up 16% on Volume Growth and Improved Margins; Raises 2008 Full Year EPS Guidance 11Health News:Air Products Reports Q1 EPS Up 16% on Volume Growth and Improved Margins; Raises 2008 Full Year EPS Guidance 12Health News:Air Products Reports Q1 EPS Up 16% on Volume Growth and Improved Margins; Raises 2008 Full Year EPS Guidance 13Health News:Air Products Reports Q1 EPS Up 16% on Volume Growth and Improved Margins; Raises 2008 Full Year EPS Guidance 14Health News:Air Products Reports Q1 EPS Up 16% on Volume Growth and Improved Margins; Raises 2008 Full Year EPS Guidance 15Health News:Air Products Reports Q1 EPS Up 16% on Volume Growth and Improved Margins; Raises 2008 Full Year EPS Guidance 16Health News:FDA Approves Labeling Change for Non-Drowsy CLARITIN(R) 2Health News:FDA Approves Labeling Change for Non-Drowsy CLARITIN(R) 3Health News:A Fort Worth Couple Sues Huguley Memorial Medical Center 2Health News:Makers of OTC Cough Medicines Reaffirm Efficacy of Products 2Health News:Iowa State University researcher's work on gender, temperature link in reptiles published in Nature 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: